Back to GUGGENHEIM CAPITAL LLC GUGGENHEIM CAPITAL LLC

AIMTAIMT
7 quarters

Position history for GUGGENHEIM CAPITAL LLCGUGGENHEIM CAPITAL LLC's holdings in AIMMUNE THERAPEUTICS INC

GUGGENHEIM CAPITAL LLC previously held 0 shares of AIMT (AIMMUNE THERAPEUTICS INC), worth $0 as of 2020-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$254,000

Total Shares Change

-11,358

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2020-Q3
New
39,629
-
$1.4M0.0%—
35
2020-Q1
Exited
0
-100.0%
$00.0%—
0
2019-Q4
Decreased
10,008
-1.4%
$335,0000.0%—
0
2019-Q3
Decreased
10,148
-8.8%
$212,0000.0%—
0
2019-Q2
Decreased
11,126
-2.0%
$232,0000.0%—
0
2019-Q1
First report
11,358
-
$254,0000.0%—
0

Other major holders of AIMT: PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used